Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- CAYER D. Prolonged anticholinergic therapy of duodenal ulcer. Am J Dig Dis. 1956 Jul;1(7):301–309. doi: 10.1007/BF02298948. [DOI] [PubMed] [Google Scholar]
- DOUTHWAITE A. H., HUNT J. N. Effect of nacton in patients with duodenal ulcer. Br Med J. 1958 May 3;1(5078):1030–1034. doi: 10.1136/bmj.1.5078.1030. [DOI] [PMC free article] [PubMed] [Google Scholar]
- KIRSNER J. B., FORD H., KASSRIEL R. S. Anticholinergic drugs in peptic ulcer; their current status. Med Clin North Am. 1957 Mar;41(2):495–520. doi: 10.1016/s0025-7125(16)34451-0. [DOI] [PubMed] [Google Scholar]
- KIRSNER J. B., LEVIN E., PALMER W. L. The effect of newer anticholinergic drugs upon gastric secretion in man. Gastroenterology. 1953 Feb;23(2):199–218. [PubMed] [Google Scholar]
- KIRSNER J. B., PALMER W. L. Newer gastric antisecretory compounds. J Am Med Assoc. 1953 Mar 7;151(10):798–805. [PubMed] [Google Scholar]
- SUN D. C., SHAY H. Optimal effective dose of anticholinergic drug in peptic ulcer therapy. AMA Arch Intern Med. 1956 Apr;97(4):442–452. doi: 10.1001/archinte.1956.00250220062006. [DOI] [PubMed] [Google Scholar]
- WOODWARD E. R., SCHAPIRO H. Relationship of ulcer pain to pH and motility of stomach and duodenum. Proc Soc Exp Biol Med. 1954 Jul;86(3):504–506. doi: 10.3181/00379727-86-21148. [DOI] [PubMed] [Google Scholar]